Glaucoma Rehabilitation Using ElectricAI Transcranial Stimulation (GREAT) - Randomized Controlled Trial Using Combined P
RecruitingNCT05874258Phase: NAStarted 2023-05-15
Summary
Glaucoma is a complex disease that can result in progressive vision loss. It is the second leading cause of blindness, accounting for 23% of permanent blindness in Hong Kong. There are no treatments t
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
80 Years
Locations
The Hong Kong Polytechnic UniversityHong Kong, Hong Kong
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT05874258